Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70
/in Hyperthermia, International PublicationsHyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line
/in Hyperthermia, International PublicationsAntigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches
/in Dendritic Cells, International PublicationsProlonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells
/in Dendritic Cells, International Publications, Malignant MelanomaEnhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death
/in Dendritic Cells, International PublicationsDendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications
/in Acute Leukemia, International PublicationsRecent advances in cancer immunotherapy with an emphasis on vaccines
/in Colorectal Cancer, International PublicationsRandomized clinical studies of anti-tumor vaccination: state of the art in 2008
/in Dendritic Cells, International Publications, IOZK VeröffentlichungenTumour vaccine approaches for CNS malignancies: progress to date
/in Dendritic Cells, Glioblastoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer